A carregar...

Baclofen in Parkinson's disease.

In a controlled trial, baclofen (mean dose 45 mg daily) signficantly increased disability from Parkinsonism in 12 patients with the long-term levodopa syndrome. Peak dose choreoathetosis was not improved but benefit was observed in all four patients with "off period dystonia." Adverse side...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lees, A J, Shaw, K M, Stern, G M
Formato: Artigo
Idioma:Inglês
Publicado em: 1978
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1083385/
https://ncbi.nlm.nih.gov/pubmed/355602
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!